131 related articles for article (PubMed ID: 8214260)
1. Nodular regenerative hyperplasia in partial hepatectomy specimens.
Washington K; Lane KL; Meyers WC
Am J Surg Pathol; 1993 Nov; 17(11):1151-8. PubMed ID: 8214260
[TBL] [Abstract][Full Text] [Related]
2. Nodular regenerative hyperplasia of the liver in hepatocellular carcinoma. An autopsy study.
Kobayashi S; Saito K; Nakanuma Y
J Clin Gastroenterol; 1993 Mar; 16(2):155-9. PubMed ID: 8385167
[TBL] [Abstract][Full Text] [Related]
3. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
[TBL] [Abstract][Full Text] [Related]
4. Mild changes of hepatic nodular regenerative hyperplasia may cause portal hypertension and be visible on reticulin but not hematoxylin and eosin staining.
Navale P; Gonzalez RS
Virchows Arch; 2021 Dec; 479(6):1145-1152. PubMed ID: 34435237
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship.
Nzeako UC; Goodman ZD; Ishak KG
Am J Gastroenterol; 1996 May; 91(5):879-84. PubMed ID: 8633575
[TBL] [Abstract][Full Text] [Related]
6. Nodular Regenerative Hyperplasia in Patients Undergoing Liver Resection for Colorectal Metastases After Chemotherapy: Risk Factors, Preoperative Assessment and Clinical Impact.
Viganò L; Rubbia-Brandt L; De Rosa G; Majno P; Langella S; Toso C; Mentha G; Capussotti L
Ann Surg Oncol; 2015 Dec; 22(13):4149-57. PubMed ID: 25845431
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of 15 cases of liver nodular regenerative hyperplasia.
Guo T; Qian J; Zhu L; Zhou W; Zhu F; Sun G; Fang X
Cell Biochem Biophys; 2012 Nov; 64(2):115-21. PubMed ID: 22707296
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: a fine-needle aspiration cytology and biopsy study.
Ojanguren I; Ariza A; Llatjós M; Castellà E; Mate JL; Navas-Palacios JJ
Hum Pathol; 1993 Aug; 24(8):905-8. PubMed ID: 7690737
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological observaton on nodular regenerative hyperplasia of the liver].
Zhou W; Chen J
Zhonghua Bing Li Xue Za Zhi; 2002 Feb; 31(1):34-7. PubMed ID: 11955333
[TBL] [Abstract][Full Text] [Related]
10. Nodular regenerative hyperplasia of the liver associated with metastases of pancreatic endocrine tumour: report of two autopsy cases.
Minato H; Nakanuma Y
Virchows Arch A Pathol Anat Histopathol; 1992; 421(2):171-4. PubMed ID: 1514247
[TBL] [Abstract][Full Text] [Related]
11. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations.
Dachman AH; Ros PR; Goodman ZD; Olmsted WW; Ishak KG
AJR Am J Roentgenol; 1987 Apr; 148(4):717-22. PubMed ID: 3548283
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
[TBL] [Abstract][Full Text] [Related]
13. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy.
Zhang X; Thomas C; Schiano TD; Thung SN; Ward SC; Fiel MI
Histopathology; 2020 Jun; 76(7):959-967. PubMed ID: 31994248
[TBL] [Abstract][Full Text] [Related]
14. Nodular Regenerative Hyperplasia: Expression Pattern of Glutamine Synthetase and a Potential Role for Hepatic Progenitor Cells.
Guilbert MC; Therrien A; Soucy G; Trudel D; Nguyen BN
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):243-248. PubMed ID: 31335486
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of hepatic nodular regenerative hyperplasia.
Siegelman ES; Outwater EK; Furth EE; Rubin R
J Magn Reson Imaging; 1995; 5(6):730-2. PubMed ID: 8748494
[TBL] [Abstract][Full Text] [Related]
16. [Nodular regenerative hyperplasia of the liver. Study of 15 cases and review of the literature].
Capron JP; Degott C; Bernuau J; Saint-Marc Girardin MF; Zafrani ES; Braillon A; Quénum C; Dhumeaux D; Benhamou JP
Gastroenterol Clin Biol; 1983 Oct; 7(10):761-9. PubMed ID: 6628910
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of hepatocellular nodular lesions.
Hytiroglou P; Theise ND
Semin Diagn Pathol; 1998 Nov; 15(4):285-99. PubMed ID: 9845429
[TBL] [Abstract][Full Text] [Related]
18. Reversibility of chemotherapy-related liver injury.
Vigano L; De Rosa G; Toso C; Andres A; Ferrero A; Roth A; Sperti E; Majno P; Rubbia-Brandt L
J Hepatol; 2017 Jul; 67(1):84-91. PubMed ID: 28284915
[TBL] [Abstract][Full Text] [Related]
19. Concomitant hepatocellular carcinoma and non-Hodgkin's lymphoma in a patient with nodular regenerative hyperplasia.
Kataoka TR; Tsukamoto Y; Kanazawa N; Izumi T; Awata N; Nishizawa Y; Ohsawa M; Ishiguro S
Pathol Int; 2006 May; 56(5):279-82. PubMed ID: 16669877
[TBL] [Abstract][Full Text] [Related]
20. The use of morphometry in the study of nodular and vascular lesions of the liver.
Wanless IR
Anal Quant Cytol Histol; 1987 Mar; 9(1):39-41. PubMed ID: 3555535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
